Arkolith/Insider Trading/BCAX/Form 4

Cohlhepp Ryan

President and COO, DirectorBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$316K
Net Open-Market Flow
-$316K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Sell(S)13K$18.16$234K210K
Mar 3, 2026Option exercise(M)13K$3.79$49K223K
Mar 3, 2026Sell(S)5K$18.16$82K205K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2026Option exercise(M)13K—$0125K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015423) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML